Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Study participants receiving active treatment saw three times the weight loss experienced by those in the placebo group
AstraZeneca has deliberately chosen not to directly compete in the GLP-1/GIP receptor agonist space a strategic choice that, while differentiating, leaves it without exposure to the highest-growth peptide market segment (65.8% of the peptide therapy market
Do All Peptide Syringes Have Attached Needles
How This Works TB-500 mimics endogenous thymosin 4, modulating inflammation and activating repair pathways including PI3K/Akt and Notch signaling to enhance angiogenesis and cell migration [1] [2]
US$ 28.82
US$ 20.03
US$ 23.54
US$ 20.85
US$ 22.69
US$ 24.69
